BRD7 and colorectal carcinoma: As c-Myc is aberrantly overexpressed or hyperactivated and exerts its pro-oncogenic roles in more than 50% of malignancies (Zwolinska et al., 2012), including CRC, we detected the effect of BRD7 on c-Myc expression.